Department of Sports Medicine, Nanbu People's Hospital (Spine, Upper Limb Orthopedics, Sports Medicine), Nanchong, China.
Department of Otorhinolaryngology Head and Neck Surgery, Nanchong Central Hospital, Beijing Anzhen Hospital, Capital Medical University, Nanchong, China.
PeerJ. 2024 Oct 30;12:e18332. doi: 10.7717/peerj.18332. eCollection 2024.
To investigate the efficacy of erector spinal plane block (ESPB) after spinal fusion surgery in this study.
The PubMed, Embase, Cochrane library, and Web of Science databases were searched with a search deadline of March 30, 2024, and Stata 15.0 was used to analyze the data from the included studies.
Nine randomized controlled trials involving 663 patients were included. Meta-analysis showed that EPSB could reduce pain scores at 2h (standard mean difference (SMD) = -0.78, 95% CI [-1.38 to -0.19], GRADE: Moderate), 6 h (SMD = -0.81, 95% CI [-1.23 to -0.38], GRADE: Moderate), 12 h (SMD = -0.59, 95% CI [-1.05 to -0.13], GRADE: Moderate), 24 h (SMD = -0.54, 95% CI [-0.86 to -0.21], GRADE: Moderate), 48 h (SMD = -0.40, 95% CI [-0.75 to -0.05], GRADE: Moderate) after spinal fusion surgery, as well as the PCA (analgesia medication use) (SMD = -1.67, 95% CI [-2.67 to -0.67], GRADE: Moderate). However, EPSB had no effect on intraoperative blood loss (SMD = -0.28, 95% CI [-1.03 to 0.47], GRADE: Low) and length of hospital stay (SMD = -0.27, 95% CI [-0.60-0.06], GRADE: Low).
Combined with the current findings, EPSB may reduce pain scores in spinal fusion surgery, possibly reducing the use of postoperative analgesics. However, due to the limitations of the study, we need more high-quality, multi-center, large sample randomized controlled trials to merge.
本研究旨在探讨脊柱融合术后竖脊肌平面阻滞(ESPB)的疗效。
检索 PubMed、Embase、Cochrane 图书馆和 Web of Science 数据库,检索截止日期为 2024 年 3 月 30 日,采用 Stata 15.0 对纳入研究进行数据分析。
纳入 9 项随机对照试验,共 663 例患者。Meta 分析显示,ESPB 可降低术后 2 h(标准均数差(SMD)=-0.78,95%CI[-1.38 至-0.19],GRADE:中度)、6 h(SMD=-0.81,95%CI[-1.23 至-0.38],GRADE:中度)、12 h(SMD=-0.59,95%CI[-1.05 至-0.13],GRADE:中度)、24 h(SMD=-0.54,95%CI[-0.86 至-0.21],GRADE:中度)、48 h(SMD=-0.40,95%CI[-0.75 至-0.05],GRADE:中度)的疼痛评分,以及 PCA(镇痛药物使用)(SMD=-1.67,95%CI[-2.67 至-0.67],GRADE:中度)。然而,ESPB 对术中失血量(SMD=-0.28,95%CI[-1.03 至 0.47],GRADE:低)和住院时间(SMD=-0.27,95%CI[-0.60-0.06],GRADE:低)无影响。
结合目前的研究结果,ESPB 可能降低脊柱融合术后的疼痛评分,可能减少术后镇痛药物的使用。然而,由于研究的局限性,我们需要更多高质量、多中心、大样本的随机对照试验来合并。